Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. It’s a step toward letting the littlest kids get vaccinated.
Highlights
- Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, May 23, 2022.
- Pfizer plans to give the data to U.S.
- regulators later this week in a step toward letting the littlest kids get the shots.
- The Food and Drug Administration already is evaluating an application by rival Moderna to offer two-dose vaccinations to tots.
- The news comes after months of anxious waiting by parents desperate to vaccinate their babies, toddlers and preschoolers.
- The 18 million youngsters under 5 are the only group not yet eligible for the vaccine.